Penn Medicine researcher, Drew Weissman, MD, PhD, a professor of Infectious Diseases, and Katalin Kariko, PhD, an adjunct associate professor who is now a senior vice president at BioNTech, developed key parts of the technology used by Pfizer/BioNTech and Moderna in their respective COVID-19 vaccines. “I think the next big act for RNA is probably going to be more vaccines (for other diseases),” Weissman said.
The mRNA technology at the heart of two Covid-19 shots has been decades in the making. Now it may soon be used to fight cancer and HIV.
Watch Video
Comments